Cepheid Prices $300M of Convertible Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Tuesday it has increased the amount of convertible senior notes it is offering and has priced them.

Cepheid raised the offering to $300 million from $250 million announced earlier this week and has granted the initial purchasers an option to purchase an additional $45 million of notes to cover any overallotments. Morgan Stanley and Jefferies are the initial purchasers of the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.